SCIENTIFIC INDUSTRIES INC: employment agreements with CFO, CEO and chairman

What happened On Oct 1, 2026 SCIENTIFIC INDUSTRIES INC entered into an employment agreement with Zachary Rovinsky, the company’s chief financial officer, providing employment through Sep 30, 2028 (extendable for two additional one-year periods by mutual consent) at an annual salary of $210,000, with a bonus up to 10% of his salary and annual salary increases of 3.0%. On Oct 1, 2026 the company extended the employment agreement with Ms. Helena Santos, president, chief executive officer and treasurer, through Sep 30, 2027; all other terms of the existing employment agreement dated Jul 1, 2017, as previously amended, remain the same except a base salary of $200,000 during the Amendment Period, part of which may be paid in equity upon mutual agreement. On Oct 1, 2026 the company’s subsidiary Scientific Bioprocessing, Inc. extended the employment agreement with Mr. John A. Moore, chairman of the board, through Sep 30, 2027; all other terms of the existing employment agreement dated Jul 1, 2020, as previously amended, remain the same except a salary of $165,000 during the Amendment Period, part of which may be paid in equity upon mutual agreement.

Key details

• CFO Zachary Rovinsky: employment through Sep 30, 2028; annual salary $210,000; bonus up to 10% of salary; annual 3.0% salary increases.
• CEO Helena Santos: agreement extended through Sep 30, 2027; base salary $200,000 during the Amendment Period; part of salary may be paid in equity upon mutual agreement.
• Chairman John A. Moore (via SBI): agreement extended through Sep 30, 2027; salary $165,000 during the Amendment Period; part of salary may be paid in equity upon mutual agreement.

Why it may matter The 8-K reports Item 1.01 (entry into a material definitive agreement) covering a new employment agreement for the CFO and amendments extending employment terms for the CEO and the chairman. The filing also includes exhibits under Item 9.01 that attach the agreements. The filing does not show why the insider traded or why the company acted.